| Origin Agritech Announces Strategic Provincial Distribution Agreement for Corn Seeds in Shandong Province and Receives RMB 2.9 Million in Initial Payments |
Globe Newswire |
10/19 |
07:00 |
| JazzCash Wins Silver Award for Innovation in InsurTech at Money20/20 USA 2026 |
Globe Newswire |
10/19 |
07:00 |
| Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM |
Globe Newswire |
10/19 |
07:00 |
| Gogo unveils Galileo roadmap to continue enhancing customer investments through the mid 2030s and beyond |
Globe Newswire |
10/19 |
07:00 |
| Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP) |
Globe Newswire |
10/19 |
07:00 |
| Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026 |
Globe Newswire |
10/19 |
07:00 |
| Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer |
Globe Newswire |
10/19 |
07:00 |
| Xanadu Secures Up to USD $10 Million in Additional DARPA Support to Accelerate Quantum R&D Roadmap |
Globe Newswire |
10/19 |
07:00 |
| EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD |
Globe Newswire |
10/19 |
07:00 |
| Ethyreal Bio Achieves Proof of Mechanism in First-in-Human Study of ETHY-001 and Initiates First Patient Cohorts to Advance Development in Thyroid Eye Disease (TED) and Graves’ Disease (GD) |
Globe Newswire |
10/19 |
07:00 |
| Owlting Group (NASDAQ: OWLS) Issues CEO Letter to Shareholders Marking One Year on Nasdaq |
Globe Newswire |
10/19 |
06:58 |
| BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026 |
Globe Newswire |
10/19 |
06:45 |
| Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site |
Globe Newswire |
10/19 |
06:45 |
| 2026 Pearl River International Trade Forum Held Successfully |
Globe Newswire |
10/19 |
06:30 |
| Press Release: Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany |
Globe Newswire |
10/19 |
06:30 |
| Washington Bets $4.2 Billion on Nuclear. Elon Musk Is Betting on the Sun. |
Globe Newswire |
10/19 |
06:30 |
| CBIZ Reports Third-Quarter and Nine Months Ended September 30, 2026 Financial Results |
Globe Newswire |
10/19 |
06:30 |
| World Maritime Equipment Conference 2026 opens in Fuzhou, Fujian |
Globe Newswire |
10/19 |
06:14 |
| QFIN Deadline Reminder: Qfin Holdings Investors are Notified to Contact BFA Law before the Expiration of the November 27 Lead Plaintiff Deadline |
Globe Newswire |
10/19 |
06:07 |
| PRTH Investigation Reminder: Priority Technology Shareholders are Notified to Contact BFA Law about the $8.05 per Share Take-Private Merger |
Globe Newswire |
10/19 |
06:07 |
| GOOG, GOOGL Deadline Reminder: Alphabet Investors are Notified to Contact BFA Law before the Expiration of the December 1 Lead Plaintiff Deadline |
Globe Newswire |
10/19 |
06:07 |
| VEON Accelerates Telecom Market Consolidation in Uzbekistan, a Market of Nearly 40 Million People |
Globe Newswire |
10/19 |
06:05 |
| Quanta Therapeutics Announces Presentation of QTX3034 Clinical Combination Data with Anti-EGFR and Chemotherapy in Colorectal Cancer (CRC) at ESMO and Fast Track Designation for Patients with KRAS G12D Mutations |
Globe Newswire |
10/19 |
06:05 |
| Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers |
Globe Newswire |
10/19 |
06:00 |
| Zymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharma |
Globe Newswire |
10/19 |
06:00 |
